Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.

Williams, Hywel C

Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. [electronic resource] - The Journal of investigative dermatology 03 2017 - 614-619 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

1523-1747

10.1016/j.jid.2016.10.019 doi


Administration, Topical
Adolescent
Adult
Aged
Aminoquinolines--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Basal Cell--drug therapy
Child
Female
Humans
Imiquimod
Male
Middle Aged
Neoplasm Recurrence, Local
Skin Neoplasms--drug therapy
Young Adult